ImageneBio

(NASDAQ) IMA

Current Price$5.70

Market Cap$67.43M

Since IPO (2025)-65%

5 Year-97%

1 Year-66%

1 Month-0%

ImageneBio Financials at a Glance

Market Cap

$67.43M

Revenue (TTM)

$0.00

Net Income (TTM)

-$45.07M

EPS (TTM)

-$5.26

P/E Ratio

-1.09

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$5.70

Volume

416.903

Open

$5.82

Price

$5.70

Volume

416.903

Open

$5.82

Previous Close

$5.71

Daily Range

$5.52 - $5.84

52-Week Range

$3.94 - $18.00

Estimated Earnings Date

Aug 7, 2026

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$5.70

Volume

416.903

Open

$5.82

Previous Close

$5.71

Daily Range

$5.52 - $5.84

52-Week Range

$3.94 - $18.00

Estimated Earnings Date

Aug 7, 2026

IMA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ImageneBio

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Kristin Yarema, PhD

Website

www.inmagenebio.com

Headquarters

San Diego, CA 92130, US

IMA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-37%

Return on Capital

-43%

Return on Assets

-33%

Earnings Yield

-91.74%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$67.43M

Shares Outstanding

11.81M

Volume

416.903

Avg. Volume

343.56K

Financials (TTM)

Gross Profit

-$233.00K

Operating Income

-$48.45M

EBITDA

-$44.67M

Operating Cash Flow

-$47.84M

Capital Expenditure

$0.00

Free Cash Flow

-$47.84M

Cash & ST Invst.

$75.79M

Total Debt

$10.00M

ImageneBio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$174.00K

+95.3%

Gross Margin

0.00%

N/A

Market Cap

$67.43M

N/A

Market Cap/Employee

$6.74M

N/A

Employees

N/A

Net Income

-$10.62M

-23.2%

EBITDA

-$10.61M

-14.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$117.21M

+2.8%

Total Debt

$8.15M

+23.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$5.84M

+114.9%

Short Term Debt

$2.31M

-40.8%

Return on Assets

-32.98%

N/A

Return on Invested Capital

-43.00%

N/A

Free Cash Flow

-$14.80M

-40.1%

Operating Cash Flow

-$14.80M

-40.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

KLRSKalaris Therapeutics Inc

KLRSKalaris Therapeutics Inc$4.54+4.02%

MGXMetagenomi, Inc. Common Stock

MGXMetagenomi, Inc. Common Stock$1.27+1.60%

IFRXInflaRx N.V.

IFRXInflaRx N.V.$1.66-1.49%

QNCXQuince Therapeutics, Inc.

QNCXQuince Therapeutics, Inc.$0.96+1.07%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.12+0.71%

CNTXContext Therapeutics Inc.

CNTXContext Therapeutics Inc.$1.47+3.17%

ARTVArtiva Biotherapeutics, Inc.

ARTVArtiva Biotherapeutics, Inc.$8.56+6.94%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.03+0.01%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.35-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.90+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.03-0.00%

DSYBig Tree Cloud

DSYBig Tree Cloud$5.26+0.35%

UBXGU-bx Technology

UBXGU-bx Technology$6.87+0.43%

INTCIntel

INTCIntel$123.81+0.06%

Questions About IMA

What is the current price of ImageneBio?

ImageneBio is trading at $5.71 per share.

What is the 52-week range for ImageneBio?

Over the past 52 weeks, ImageneBio has traded between $3.94 and $18.00.

How much debt does ImageneBio have?

As of the most recent reporting period, ImageneBio reported total debt of $8.15M.

How much cash does ImageneBio have on hand?

ImageneBio reported $76.05M in cash and cash equivalents in its most recent financial results.

What is ImageneBio’s dividend yield?

ImageneBio does not currently have a dividend yield.

ImageneBio

ImageneBio Financials at a Glance

IMA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ImageneBio

IMA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ImageneBio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMA

What is the current price of ImageneBio?

What is the 52-week range for ImageneBio?

How much debt does ImageneBio have?

How much cash does ImageneBio have on hand?

What is ImageneBio’s dividend yield?

Premium Investing Services